Gerd Nöldge

Gerd Nöldge

Auto-generated profile, based on publicly available information

Gerd Nöldge

Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
SGStefanie Nicole Garni
Stefanie Nicole Garni
NMNando Mertineit
Nando Mertineit
GNGerd Nöldge
Gerd Nöldge
KDKeivan Daneshvar
Keivan Daneshvar
FMFrank Mosler
Frank Mosler
Artificial intelligence (AI) is increasingly employed in radiation protection, encompassing both medical devices and software. These technologies are integrated with AI throughout their manufacturing and application processes. This article underscores the imperative for comprehensive regulation in the utilization of AI. Decisions regarding AI application should not solely rest with manufacturers, medical professionals, or patients. Instead, an overarching "neutral" authority must be engaged to regulate, review, and enforce adherence to established protocols. The authors contend that relying on "self-regulation" within the free market, absent clear guidelines, proves to be inadequately effective and leads to patient's radiation protection safety issues.

27 April 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
JSJan Felix Senge
Jan Felix Senge
MMMatthew T McMurray
Matthew T McMurray
FHFabian Haupt
Fabian Haupt
PBPhilipe S. Breiding
Philipe S. Breiding
CBClaus Beisbart
Claus Beisbart
WBWolfram Bosbach
Wolfram Bosbach
Motive: Documentation and administration occupy a substantial part of the working time in interventional radiology. Automated drafting tools may assist with these tasks, but their potential benefit requires evaluation. Method: Three predefined simulated cases of peripherally inserted central catheter (PICC) insertion were used to generate reports with ChatGPT on 4 May 2023, using items from the Radiological Society of North America (RSNA) template. Five iterations per case produced 15 report drafts. Eight radiologists, including six board-certified radiologists and two residents, rated completeness, structure, apparent AI authorship, readiness for use without editing and anticipated time savings. Key results: Raters generally assessed completeness and structure positively and anticipated time savings. They generally disagreed that the drafts were clearly identifiable as AI-generated. Some drafts required editing, particularly in relation to report structure and the handling of complications. Documentation time was not measured, and a controlled comparison with human-written reports was not performed. Conclusions: This small simulation study supports the feasibility of AI-assisted PICC report drafting and describes favourable perceptions among the participating raters. It does not establish actual time savings, equivalent report quality or indistinguishability from human-written reports. Prospective evaluation of drafting time, editing requirements and clinical accuracy is needed before conclusions about routine clinical benefit can be drawn.

1 June 2023 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
FMFrank Mosler
Frank Mosler
NMNando Mertineit
Nando Mertineit
GNGerd Nöldge
Gerd Nöldge
Characteristic of the osteoid osteoma is the so-called nidus enclosed in the tumor and produces a typical picture on X-ray. Since most physicians have little experience with the clinical picture of osteoid osteoma, this is an important reason for the often-long anamnesis time for osteoid osteoma (OO). The period of formation of OO includes the phase of strongest bone growth in childhood and adolescence. The most characteristic clinical symptom is nocturnal attacks of pain around the tumor, which occur independently of preceding physical activity and respond strikingly well to non-steroidal anti-inflammatory drugs (aspirin test). OO most frequently affects the long tubular bones of the lower extremities. Fifty percent of OO are found in the femur and tibia preferentially occurring in the corticalis of metaphysis and diaphysis. This is followed by the long tubular bones of the upper extremity and the short tubular bones. However, any other bone can also be affected. Differentially, osteoblastoma or osteosarcoma must be considered first and foremost. Most widely accepted therapy options are open surgery with en-bloc resection of the tumor, excochleation,minimally invasive percutaneous CT-guided radio or laser ablation. A conservative management by pharmaceutical pain therapy should be reserved for cases in which surgery must be refused either because of the precarious position of the nidus or because the patient's general condition does not permit it, or the patient does not consent to surgical interventions.

30 January 2026 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
ZMZainab Magomedova
Zainab Magomedova
EPEkaterina S. Pershina
Ekaterina S. Pershina
KDKeivan Daneshvar
Keivan Daneshvar
GNGerd Nöldge
Gerd Nöldge
MFMosler Frank
Mosler Frank
Artificial intelligence (AI) has rapidly evolved into a transformative force in radiology, complementing human intelligence across the entire imaging workflow. Current applications range from image acquisition and reconstruction to automated detection, quantification, triage, and clinical decision support. Evidence to date demonstrates that AI systems can match or exceed human performance in narrowly defined tasks, particularly in pattern recognition and workflow optimization. However, robust prospective validation, demonstration of clinical impact, and proof of generalizability across institutions and populations remain limited. Human intelligence continues to play a central role in contextual interpretation, integration of clinical information, ethical judgment, and responsibility for patient care. Rather than replacing radiologists, AI is increasingly viewed as an augmentative tool that enhances diagnostic accuracy, efficiency, and consistency when appropriately implemented. Regulatory frameworks are evolving in response to these developments. In Europe, the Medical Device Regulation (MDR) and the forthcoming AI Act introduce stricter requirements for transparency, risk classification, post-market surveillance, and human oversight. Comparable regulatory efforts are underway globally, aiming to balance innovation with patient safety, data protection, and accountability. Nonetheless, regulatory heterogeneity and the dynamic nature of adaptive AI systems pose ongoing challenges. Looking ahead, the future of radiology will be shaped by closer human–AI collaboration, increased emphasis on explainability, continuous learning systems under regulatory control, and higher-quality clinical evidence. Education and training of radiologists in AI literacy will be essential. Ultimately, the successful integration of artificial intelligence into radiology will depend not only on technological progress, but also on evidence-based implementation, clear regulation, and sustained human expertise. ----------------------------------------------------------------------------- Contents: 1. Introduction 2. Methods / Sources 3. Radiology Today: Clinical Role and Value Contribution 4. Radiation Protection as Culture (Technology, Behavior, Organization) 5. AI in Radiology: Application Areas and Evidence 6. Generative AI: Support Rather Than Replacement 7. Regulation, Governance, and Quality Assurance 8. Limits of Current Systems: “Common Sense” and Explainability 9. Outlook: Agentive Systems and Division of Labor 10. Practical Checklist: Governance & Safe Implementation 1. Introduction Artificial intelligence (AI) has rapidly evolved into a transformative force in radiology, complementing human intelligence across the entire imaging workflow. Current applications range from image acquisition and reconstruction to automated detection, quantification, triage, and clinical decision support. Evidence to date demonstrates that AI systems can match or exceed human performance in narrowly defined tasks, particularly in pattern recognition and workflow optimization. However, robust prospective validation, demonstration of clinical impact, and proof of generalizability across institutions and populations remain limited. Human intelligence continues to play a central role in contextual interpretation, integration of clinical information, ethical judgment, and responsibility for patient care. Rather than replacing radiologists, AI is increasingly viewed as an augmentative tool that enhances diagnostic accuracy, efficiency, and consistency when appropriately implemented. Regulatory frameworks are evolving in response to these developments. In Europe, the Medical Device Regulation (MDR) and the forthcoming AI Act introduce stricter requirements for transparency, risk classification, post-market surveillance, and human oversight. Comparable regulatory efforts are underway globally, aiming to balance innovation with patient safety, data protection, and accountability. Nonetheless, regulatory heterogeneity and the dynamic nature of adaptive AI systems pose ongoing challenges. Looking ahead, the future of radiology will be shaped by closer human–AI collaboration, increased emphasis on explainability, continuous learning systems under regulatory control, and higher-quality clinical evidence. Education and training of radiologists in AI literacy will be essential. Ultimately, the successful integration of artificial intelligence into radiology will depend not only on technological progress, but also on evidence-based implementation, clear regulation, and sustained human expertise. 2. Methods and Sources The present article is based on a curated, critical analysis of recent high-quality literature addressing the role of artificial intelligence (AI) in radiology. The purpose of this chapter is not to provide a systematic review in the strict methodological sense, but rather to transparently describe the sources used and to analyze how contemporary publications conceptualize, evaluate, and contextualize AI within clinical radiology. Emphasis is placed on methodological rigor, evidence generation, human–AI interaction, and regulatory framing. The selected time frame (2022–2025) captures a period that followed an initial phase of considerable enthusiasm surrounding AI in radiology. During the years preceding this interval, AI was frequently portrayed as a disruptive technology with the potential to fundamentally transform diagnostic imaging, often accompanied by claims of near-human or superhuman performance. More recent publications, however, reflect a noticeable shift toward a more cautious and sober assessment. This phase is characterized by increased attention to real-world performance, unintended consequences of AI deployment, limitations of retrospective evidence, and the growing influence of regulatory requirements (11). Against this background, the present analysis aims to examine how...

30 March 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
NMNando Mertineit
Nando Mertineit
CTCarlos Buitrago Tellez
Carlos Buitrago Tellez
PKPascal Kissling
Pascal Kissling
FMFrank Mosler
Frank Mosler
JHJohannes Heverhagen
Johannes Heverhagen
GNGerd Nöldge
Gerd Nöldge
The therapy of pelvic aneurysms is minimally invasive through interventional radiology using various devices and embolic agents: 1. By using a covered stent/prosthesis to maintain antegrade flow when a landing zone, i.e., a vascular segment angiographically present into which the stent can be placed to bridge the neck of the aneurysm, thereby interrupting aneurysm perfusion. 2. Through complete embolization of the aneurysm using embolic agents/coils. 3. As performed in our case, by covering the aneurysm (Img 14 A-C) with a covered stent /prosthesis, following prior embolization of the branching vessels using macroembolic agents. In cases where there is insufficient occlusion of the aneurysm with residual perfusion, secondary em- bolization becomes considerably more complex due to the occlusion of the anatomically antegrade access and the altered hemodynamics around the aneurysm causing retrograde collateralization. Through detailed analysis of CT angiography, even in static CT, retrograde circulation could be iden- tified, allowing for a minimally invasive secondary approach to the aneurysm without the need for general anesthesia and/or surgery. By completely eliminating the aneurysm, the risk of rupture in the elderly patient was minimally invasively eliminated. The treatment of this patient exemplifies the possibilities that embolization with a wide array of embolic agents and catheters offers in a hemo- dynamically very complex situation.

30 March 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
KDKeivan Daneshvar
Keivan Daneshvar
WBWolfram Bosbach
Wolfram Bosbach
NMNando Mertineit
Nando Mertineit
GNGerd Nöldge
Gerd Nöldge
FMFrank Mosler
Frank Mosler
The second most common hematologic malignancy is the clonal proliferation of neoplastic plasma cells within the bone marrow. There is the presence of monoclonal immunoglobulins in the serum and/or urine. This results in anemia, myelosuppression, bone destruction, and clinical consequences of paraproteinemia on kidney function and other organ systems. The disease manifests through the acronym CRAB (hypercalcemia, renal impairment, anemia, and bone lesions). Less frequent manifestations of multiple myeloma are of extramedullary localizations. Myeloma cells can become independent of the bone marrow microenvironment, circulate freely in the blood, and infiltrate organs. This results in a high-risk state characterized by increased proliferation, evasion of apoptosis, and treatment resistance. It can affect any area of tissue. Most commonly it involves the pleura, lymph nodes, chest wall, liver, skin/soft tissue, lungs, CNS, genitourinary system, breast and pancreas. In patients with confirmed multiple myeloma, the diagnosis of extramedullary involvement is typically established by the presence of pathological soft tissue masses using radiological methods such as computed tomography (CT) scan, positron emission tomography/CT (PET/CT), magnetic resonance imaging (MRI), or ultrasound, along with biopsy or physical examination. The molecular mechanisms underlying the development of extramedullary multiple myeloma (EMM) have not been fully defined. Various cytogenetic abnormalities are observed, and some studies have generated genomic sequencing profiles that distinguish EMM from classic multiple myeloma. While plasma cell leukemia (PCL) and central nervous system (CNS) EMM indicate a poor prognosis, outcomes for other manifestations can be highly heterogeneous. Sensitive imaging modalities including PET/CT and MRI (Fig.1) are integral components of diagnosis and response assessment. Patients with extramedullary multiple myeloma (EMM) have a clear survival disadvantage.